Review



murine tweak injection  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems murine tweak injection
    FIGURE 5 <t>TWEAK</t> enhances plaque instability in CD163 deficient mice. A, Representative photographs of α-SMA + DAPI and CD68 stained sections. Quantification of CD68 and α-SMA in aortic root <t>from</t> <t>ApoE−/−CD163+/+</t> and ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD in the right panel. Values shown are mean ± SEM of 8-9 animals per group. *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. B, Percentage of each grade from Stary method between different groups. N = 20-25 plaques per group. C, Relative CCL2 and CCL5 mRNA expression levels normalized to 18S rRNA of aortas from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of six animals per group; *P < .001 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. D, Representative images of BCA cross sections stained with MOVAT from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Dashed lines show the boundary of the developing necrotic area (NC). Quantification of the necrotic core area is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. E, LDH activity in serum from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW and rCD. Data represent the mean ± SEM of six animals per group; *P < .001, vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW. One-way ANOVA with Bonferroni's posttest. F, Frequency of morphological markers of plaque instability in ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. G, Representative images of BCA cross sections stained with α-SMA or CD68 from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Quantification CD68 positive cells is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm
    Murine Tweak Injection, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine tweak injection/product/R&D Systems
    Average 94 stars, based on 22 article reviews
    murine tweak injection - by Bioz Stars, 2026-06
    94/100 stars

    Images

    1) Product Images from "CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice"

    Article Title: CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice

    Journal: The FASEB Journal

    doi: 10.1096/fj.202000177r

    FIGURE 5 TWEAK enhances plaque instability in CD163 deficient mice. A, Representative photographs of α-SMA + DAPI and CD68 stained sections. Quantification of CD68 and α-SMA in aortic root from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD in the right panel. Values shown are mean ± SEM of 8-9 animals per group. *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. B, Percentage of each grade from Stary method between different groups. N = 20-25 plaques per group. C, Relative CCL2 and CCL5 mRNA expression levels normalized to 18S rRNA of aortas from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of six animals per group; *P < .001 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. D, Representative images of BCA cross sections stained with MOVAT from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Dashed lines show the boundary of the developing necrotic area (NC). Quantification of the necrotic core area is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. E, LDH activity in serum from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW and rCD. Data represent the mean ± SEM of six animals per group; *P < .001, vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW. One-way ANOVA with Bonferroni's posttest. F, Frequency of morphological markers of plaque instability in ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. G, Representative images of BCA cross sections stained with α-SMA or CD68 from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Quantification CD68 positive cells is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm
    Figure Legend Snippet: FIGURE 5 TWEAK enhances plaque instability in CD163 deficient mice. A, Representative photographs of α-SMA + DAPI and CD68 stained sections. Quantification of CD68 and α-SMA in aortic root from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD in the right panel. Values shown are mean ± SEM of 8-9 animals per group. *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. B, Percentage of each grade from Stary method between different groups. N = 20-25 plaques per group. C, Relative CCL2 and CCL5 mRNA expression levels normalized to 18S rRNA of aortas from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of six animals per group; *P < .001 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. D, Representative images of BCA cross sections stained with MOVAT from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Dashed lines show the boundary of the developing necrotic area (NC). Quantification of the necrotic core area is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. E, LDH activity in serum from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW and rCD. Data represent the mean ± SEM of six animals per group; *P < .001, vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW. One-way ANOVA with Bonferroni's posttest. F, Frequency of morphological markers of plaque instability in ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. G, Representative images of BCA cross sections stained with α-SMA or CD68 from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Quantification CD68 positive cells is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm

    Techniques Used: Staining, Expressing, Activity Assay

    FIGURE 6 CD163 prevents pro-inflammatory actions induced by TWEAK. A, Representative western blot analysis of p-p65 and p65 in VSMCs treated with 0% FBS (control), rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL). Right panel show the quantification of band densitometry values of p-p65 protein levels expressed in arbitrary units after correction for p65 (loading control). *P < .01 vs Control; †P < .01 vs rTW; Student's t test. B, Relative CCL2, CCL5, ICAM-1, MMP-2, and MMP-9 mRNA expression levels normalized to 18S rRNA of VSMCs treated with rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL) during 24 hours. The same cDNA was repeatedly tested for multiple genes. Data represent the mean ± SEM of three independent experiments. *P < .05 vs Control; †P < .05 vs rTW. Student's t test. C, Effect of CD163 on CCL2 and CCL5 secretion induced by TWEAK in VSMCs. VSMCs were incubated with rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL) during 24 hours and supernatants were tested by ELISA for CCL2 or CCL5. Data represent the mean ± SEM of six independent experiments; *P < .001 vs control; †P < .001 vs rTW; Student's t test. D, Peritoneal macrophages were seeded in the upper surface of chemotaxis chambers and stimulated with the supernatants of VSMCs treated with 0% FBS (control), rTWEAK (100 ng/mL) or rTW plus rCD (0.1-0.5 μg/mL). Quantification of migrated cells in 10 fields per condition is shown in the right panel. Data represent the mean ± SEM of four independent experiments; *P < .001 vs Control; †P < .001 vs rTW; Student's t test. Scale bars, 50 μm
    Figure Legend Snippet: FIGURE 6 CD163 prevents pro-inflammatory actions induced by TWEAK. A, Representative western blot analysis of p-p65 and p65 in VSMCs treated with 0% FBS (control), rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL). Right panel show the quantification of band densitometry values of p-p65 protein levels expressed in arbitrary units after correction for p65 (loading control). *P < .01 vs Control; †P < .01 vs rTW; Student's t test. B, Relative CCL2, CCL5, ICAM-1, MMP-2, and MMP-9 mRNA expression levels normalized to 18S rRNA of VSMCs treated with rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL) during 24 hours. The same cDNA was repeatedly tested for multiple genes. Data represent the mean ± SEM of three independent experiments. *P < .05 vs Control; †P < .05 vs rTW. Student's t test. C, Effect of CD163 on CCL2 and CCL5 secretion induced by TWEAK in VSMCs. VSMCs were incubated with rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL) during 24 hours and supernatants were tested by ELISA for CCL2 or CCL5. Data represent the mean ± SEM of six independent experiments; *P < .001 vs control; †P < .001 vs rTW; Student's t test. D, Peritoneal macrophages were seeded in the upper surface of chemotaxis chambers and stimulated with the supernatants of VSMCs treated with 0% FBS (control), rTWEAK (100 ng/mL) or rTW plus rCD (0.1-0.5 μg/mL). Quantification of migrated cells in 10 fields per condition is shown in the right panel. Data represent the mean ± SEM of four independent experiments; *P < .001 vs Control; †P < .001 vs rTW; Student's t test. Scale bars, 50 μm

    Techniques Used: Western Blot, Control, Expressing, Incubation, Enzyme-linked Immunosorbent Assay, Chemotaxis Assay



    Similar Products

    murine tweak injection  (R&D Systems)
    94
    R&D Systems murine tweak injection
    FIGURE 5 <t>TWEAK</t> enhances plaque instability in CD163 deficient mice. A, Representative photographs of α-SMA + DAPI and CD68 stained sections. Quantification of CD68 and α-SMA in aortic root <t>from</t> <t>ApoE−/−CD163+/+</t> and ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD in the right panel. Values shown are mean ± SEM of 8-9 animals per group. *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. B, Percentage of each grade from Stary method between different groups. N = 20-25 plaques per group. C, Relative CCL2 and CCL5 mRNA expression levels normalized to 18S rRNA of aortas from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of six animals per group; *P < .001 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. D, Representative images of BCA cross sections stained with MOVAT from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Dashed lines show the boundary of the developing necrotic area (NC). Quantification of the necrotic core area is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. E, LDH activity in serum from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW and rCD. Data represent the mean ± SEM of six animals per group; *P < .001, vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW. One-way ANOVA with Bonferroni's posttest. F, Frequency of morphological markers of plaque instability in ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. G, Representative images of BCA cross sections stained with α-SMA or CD68 from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Quantification CD68 positive cells is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm
    Murine Tweak Injection, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine tweak injection/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    murine tweak injection - by Bioz Stars, 2026-06
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    FIGURE 5 TWEAK enhances plaque instability in CD163 deficient mice. A, Representative photographs of α-SMA + DAPI and CD68 stained sections. Quantification of CD68 and α-SMA in aortic root from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD in the right panel. Values shown are mean ± SEM of 8-9 animals per group. *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. B, Percentage of each grade from Stary method between different groups. N = 20-25 plaques per group. C, Relative CCL2 and CCL5 mRNA expression levels normalized to 18S rRNA of aortas from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of six animals per group; *P < .001 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. D, Representative images of BCA cross sections stained with MOVAT from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Dashed lines show the boundary of the developing necrotic area (NC). Quantification of the necrotic core area is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. E, LDH activity in serum from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW and rCD. Data represent the mean ± SEM of six animals per group; *P < .001, vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW. One-way ANOVA with Bonferroni's posttest. F, Frequency of morphological markers of plaque instability in ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. G, Representative images of BCA cross sections stained with α-SMA or CD68 from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Quantification CD68 positive cells is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm

    Journal: The FASEB Journal

    Article Title: CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice

    doi: 10.1096/fj.202000177r

    Figure Lengend Snippet: FIGURE 5 TWEAK enhances plaque instability in CD163 deficient mice. A, Representative photographs of α-SMA + DAPI and CD68 stained sections. Quantification of CD68 and α-SMA in aortic root from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD in the right panel. Values shown are mean ± SEM of 8-9 animals per group. *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. B, Percentage of each grade from Stary method between different groups. N = 20-25 plaques per group. C, Relative CCL2 and CCL5 mRNA expression levels normalized to 18S rRNA of aortas from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of six animals per group; *P < .001 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. D, Representative images of BCA cross sections stained with MOVAT from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Dashed lines show the boundary of the developing necrotic area (NC). Quantification of the necrotic core area is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm. E, LDH activity in serum from ApoE−/−CD163+/+ and ApoE−/−CD163−/− mice treated with rTW alone or rTW and rCD. Data represent the mean ± SEM of six animals per group; *P < .001, vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW. One-way ANOVA with Bonferroni's posttest. F, Frequency of morphological markers of plaque instability in ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW. †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. G, Representative images of BCA cross sections stained with α-SMA or CD68 from ApoE−/−CD163+/+ or ApoE−/−CD163−/− mice treated with rTW alone or rTW plus rCD. Quantification CD68 positive cells is shown in the below panel. Data represent the mean ± SEM of eight animals per group; *P < .05 vs ApoE−/−CD163+/+ + rTW; †P < .001 vs ApoE−/−CD163−/− + rTW; One-way ANOVA with Bonferroni's posttest. Scale bar, 100 μm

    Article Snippet: In addition, TWEAKaccelerated atherosclerosis was induced in 12-week-old ApoE−/−CD163-/- (N = 10), and ApoE−/−CD163-/- (N = 10) feeding a hyperlipidemic diet by murine TWEAK injection (5 μg/kg/three times per week; 1237-TW; R&D Systems) during the last 4 weeks.

    Techniques: Staining, Expressing, Activity Assay

    FIGURE 6 CD163 prevents pro-inflammatory actions induced by TWEAK. A, Representative western blot analysis of p-p65 and p65 in VSMCs treated with 0% FBS (control), rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL). Right panel show the quantification of band densitometry values of p-p65 protein levels expressed in arbitrary units after correction for p65 (loading control). *P < .01 vs Control; †P < .01 vs rTW; Student's t test. B, Relative CCL2, CCL5, ICAM-1, MMP-2, and MMP-9 mRNA expression levels normalized to 18S rRNA of VSMCs treated with rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL) during 24 hours. The same cDNA was repeatedly tested for multiple genes. Data represent the mean ± SEM of three independent experiments. *P < .05 vs Control; †P < .05 vs rTW. Student's t test. C, Effect of CD163 on CCL2 and CCL5 secretion induced by TWEAK in VSMCs. VSMCs were incubated with rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL) during 24 hours and supernatants were tested by ELISA for CCL2 or CCL5. Data represent the mean ± SEM of six independent experiments; *P < .001 vs control; †P < .001 vs rTW; Student's t test. D, Peritoneal macrophages were seeded in the upper surface of chemotaxis chambers and stimulated with the supernatants of VSMCs treated with 0% FBS (control), rTWEAK (100 ng/mL) or rTW plus rCD (0.1-0.5 μg/mL). Quantification of migrated cells in 10 fields per condition is shown in the right panel. Data represent the mean ± SEM of four independent experiments; *P < .001 vs Control; †P < .001 vs rTW; Student's t test. Scale bars, 50 μm

    Journal: The FASEB Journal

    Article Title: CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice

    doi: 10.1096/fj.202000177r

    Figure Lengend Snippet: FIGURE 6 CD163 prevents pro-inflammatory actions induced by TWEAK. A, Representative western blot analysis of p-p65 and p65 in VSMCs treated with 0% FBS (control), rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL). Right panel show the quantification of band densitometry values of p-p65 protein levels expressed in arbitrary units after correction for p65 (loading control). *P < .01 vs Control; †P < .01 vs rTW; Student's t test. B, Relative CCL2, CCL5, ICAM-1, MMP-2, and MMP-9 mRNA expression levels normalized to 18S rRNA of VSMCs treated with rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL) during 24 hours. The same cDNA was repeatedly tested for multiple genes. Data represent the mean ± SEM of three independent experiments. *P < .05 vs Control; †P < .05 vs rTW. Student's t test. C, Effect of CD163 on CCL2 and CCL5 secretion induced by TWEAK in VSMCs. VSMCs were incubated with rTW (100 ng/mL) or rTW plus rCD (0.01-0.5 μg/mL) during 24 hours and supernatants were tested by ELISA for CCL2 or CCL5. Data represent the mean ± SEM of six independent experiments; *P < .001 vs control; †P < .001 vs rTW; Student's t test. D, Peritoneal macrophages were seeded in the upper surface of chemotaxis chambers and stimulated with the supernatants of VSMCs treated with 0% FBS (control), rTWEAK (100 ng/mL) or rTW plus rCD (0.1-0.5 μg/mL). Quantification of migrated cells in 10 fields per condition is shown in the right panel. Data represent the mean ± SEM of four independent experiments; *P < .001 vs Control; †P < .001 vs rTW; Student's t test. Scale bars, 50 μm

    Article Snippet: In addition, TWEAKaccelerated atherosclerosis was induced in 12-week-old ApoE−/−CD163-/- (N = 10), and ApoE−/−CD163-/- (N = 10) feeding a hyperlipidemic diet by murine TWEAK injection (5 μg/kg/three times per week; 1237-TW; R&D Systems) during the last 4 weeks.

    Techniques: Western Blot, Control, Expressing, Incubation, Enzyme-linked Immunosorbent Assay, Chemotaxis Assay